Thor Lab

Research in my lab includes:

  • Markers of breast cancer prognosis or chemotherapeutic response prediction
  • Mechanisms of carcinogenesis involving the receptor tyrosine kinase gene family
  • Molecular and epigenetic factors which may contribute to breast cancer susceptibility
ThorA_web

Ann Thor MD

Professor - Todd Chair of Pathology - Cytopathology/Breast Cancer Research
  • Pathology (SOM)

Email Address: ann.thor@cuanschutz.edu

Primary Phone: 303-724-3704

CU Doctors Website

CU Doctors Profile

Education, Licensure & Certifications

Education:

  • BS; University of California, Berkeley, CA (Highest Honors) (1977)
  • MD; Vanderbilt University School of Medicine, Nashville, TN (1981)

Postdoctoral Education: 

  • Pathology Residency; Vanderbilt University Hospital, Nashville, TN (1981-1983)
  • Pathology Fellowship; Ludwig Institute for Cancer Research, Sutton Branch, Royal Marrsden Hospital, England (1983)
  • Medical Staff Fellowship; Laboratory of Tumor Immunology and Biology, Laboratory of Pathology, National Cancer Institute, National Institute of Health, Bethesda, MD (1983-1986)
  • Cytology and Surgical Pathology Fellowship/Clinical Instructor; Department of Pathology, University of California, San Francisco, CA (1986-1987)
  • Fine Needle Aspiration Fellowship; Department of Cytology, Karolinska Institute and Hospital, Stockholm, Sweden (1987)
  • Funded Fellowship in Gynecologic Pathology, American Cancer Society's Cancer Development Award; Massachusetts General Hospital, Boston, MA (1987-1990)
  • Fellowship; Executive Leadership in Academic Medicine (ELAM) Program for Women (2000-2001)
  • Breast Ductal Fluid Cytology Training and Certification (2001)
  • Gynecologic Pathology Certification; CytoPro Gyn Cytology Proficiency Examination (2005)